These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 31063770

  • 1. Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons.
    Nakamura M, Cho JH, Shin H, Jang IS.
    Eur J Pharmacol; 2019 Jul 15; 855():175-182. PubMed ID: 31063770
    [Abstract] [Full Text] [Related]

  • 2. Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate.
    Sharma R, Nakamura M, Neupane C, Jeon BH, Shin H, Melnick SM, Glenn KJ, Jang IS, Park JB.
    Eur J Pharmacol; 2020 Jul 15; 879():173117. PubMed ID: 32325146
    [Abstract] [Full Text] [Related]

  • 3. Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na(+) current than on the persistent Na(+) current in central neurons.
    Terragni B, Scalmani P, Colombo E, Franceschetti S, Mantegazza M.
    Neuropharmacology; 2016 Nov 15; 110(Pt A):223-236. PubMed ID: 27450092
    [Abstract] [Full Text] [Related]

  • 4. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons.
    Liu Y, Yohrling GJ, Wang Y, Hutchinson TL, Brenneman DE, Flores CM, Zhao B.
    Epilepsy Res; 2009 Jan 15; 83(1):66-72. PubMed ID: 19013768
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
    Lattanzi S, Trinka E, Zaccara G, Striano P, Del Giovane C, Silvestrini M, Brigo F.
    CNS Drugs; 2020 Nov 15; 34(11):1105-1120. PubMed ID: 32851590
    [Abstract] [Full Text] [Related]

  • 6. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
    Ilyin VI, Hodges DD, Whittemore ER, Carter RB, Cai SX, Woodward RM.
    Br J Pharmacol; 2005 Mar 15; 144(6):801-12. PubMed ID: 15778702
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of in vitro and in vivo high glucose-induced alterations in voltage-gated tetrodotoxin-resistant sodium channel: Effects attenuated by sodium channel blockers.
    Kharatmal SB, Singh JN, Sharma SS.
    Neuroscience; 2015 Oct 01; 305():183-96. PubMed ID: 26255676
    [Abstract] [Full Text] [Related]

  • 8. Propranolol modulation of tetrodotoxin-resistant Na+ channels in dural afferent neurons.
    Nakamura M, Jang IS.
    Eur J Pharmacol; 2021 Nov 05; 910():174449. PubMed ID: 34454925
    [Abstract] [Full Text] [Related]

  • 9. Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats.
    Remy S, Urban BW, Elger CE, Beck H.
    Eur J Neurosci; 2003 Jun 05; 17(12):2648-58. PubMed ID: 12823472
    [Abstract] [Full Text] [Related]

  • 10. The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons.
    Huang CW, Huang CC, Lin MW, Tsai JJ, Wu SN.
    Int J Neuropsychopharmacol; 2008 Aug 05; 11(5):597-610. PubMed ID: 18184444
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW.
    Expert Rev Neurother; 2020 Nov 05; 20(11):1085-1098. PubMed ID: 33031714
    [Abstract] [Full Text] [Related]

  • 12. Slowly inactivating component of Na+ current in peri-somatic region of hippocampal CA1 pyramidal neurons.
    Park YY, Johnston D, Gray R.
    J Neurophysiol; 2013 Mar 05; 109(5):1378-90. PubMed ID: 23236005
    [Abstract] [Full Text] [Related]

  • 13. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
    Thériault O, Poulin H, Sculptoreanu A, de Groat WC, O'Leary ME, Chahine M.
    Eur J Pharmacol; 2014 Mar 15; 727():158-66. PubMed ID: 24486399
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca²⁺ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER).
    Yan HD, Ishihara K, Seki T, Hanaya R, Kurisu K, Arita K, Serikawa T, Sasa M.
    Brain Res Bull; 2013 Jan 15; 90():142-8. PubMed ID: 23107646
    [Abstract] [Full Text] [Related]

  • 15. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
    Kahlig KM, Hirakawa R, Liu L, George AL, Belardinelli L, Rajamani S.
    Mol Pharmacol; 2014 Jan 15; 85(1):162-74. PubMed ID: 24202911
    [Abstract] [Full Text] [Related]

  • 16. Cholesterol metabolite cholestane-3β,5α,6β-triol suppresses epileptic seizures by negative modulation of voltage-gated sodium channels.
    Tang L, Wang Y, Leng T, Sun H, Zhou Y, Zhu W, Qiu P, Zhang J, Lu B, Yan M, Chen W, Su X, Yin W, Huang Y, Hu H, Yan G.
    Steroids; 2015 Jun 15; 98():166-72. PubMed ID: 25578735
    [Abstract] [Full Text] [Related]

  • 17. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons.
    Zhao J, Xu L, Zhang T, Ren G, Yang Z.
    Neurotoxicology; 2009 Mar 15; 30(2):220-30. PubMed ID: 19146874
    [Abstract] [Full Text] [Related]

  • 18. BmK AEP, an Anti-Epileptic Peptide Distinctly Affects the Gating of Brain Subtypes of Voltage-Gated Sodium Channels.
    Zhang F, Wu Y, Zou X, Tang Q, Zhao F, Cao Z.
    Int J Mol Sci; 2019 Feb 08; 20(3):. PubMed ID: 30744067
    [Abstract] [Full Text] [Related]

  • 19. Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons.
    Deng HM, Yin ST, Yan D, Tang ML, Li CC, Chen JT, Wang M, Ruan DY.
    Toxicology; 2008 Oct 30; 252(1-3):1-8. PubMed ID: 18706964
    [Abstract] [Full Text] [Related]

  • 20. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.
    Wengert ER, Saga AU, Panchal PS, Barker BS, Patel MK.
    Neuropharmacology; 2019 Nov 01; 158():107699. PubMed ID: 31278928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.